• Puromycin dihydrochloride: Precision Selection & Translation

  2026-05-22

  Puromycin dihydrochloride, the benchmark aminonucleoside antibiotic, enables robust selection workflows and translational process studies across diverse cell systems. This guide translates new AAV targeting findings into practical assay enhancements and delivers troubleshooting strategies to maximize reproducibility.

• Immunoproteasome-Mediated IL-4Rα Degradation in Airway Infla

  2026-05-21

  This study reveals that the immunoproteasome, particularly its LMP7 subunit, regulates type 2 airway inflammation by promoting degradation of IL-4Rα. The findings clarify how immunoproteasome activity limits airway hyperresponsiveness and suggest new mechanistic avenues for targeting allergic asthma.

• Dual-Action p38α Inhibitors Accelerate Dephosphorylation Dyn

  2026-05-21

  This study uncovers how certain p38α MAP kinase inhibitors not only block kinase activity but also actively promote phosphatase-mediated dephosphorylation through conformational modulation. The findings highlight a dual-action mechanism with significant implications for designing more selective and potent anti-inflammatory and vascular research agents.

• PMS-Induced Osteogenesis via GPR30/PI3K/Akt Pathway in Osteo

  2026-05-20

  This study elucidates how the novel PMS combination—comprising psoralen, magnoflorine, and sweroside—promotes osteoblastic activity and counteracts osteoporosis through GPR30/PI3K/Akt pathway activation. By integrating zebrafish and pre-osteoblastic cell models, the research advances mechanistic understanding of estrogen signaling in bone health, providing a framework for future targeted interventions.

• ICG001: Wnt/β-Catenin Pathway Inhibitor for Fibrosis Models

  2026-05-20

  ICG001 enables targeted dissection of Wnt/β-catenin signaling, directly supporting advanced models of fibrosis and cancer. By selectively blocking CBP/β-catenin interactions, it empowers high-fidelity EMT studies and translational research in disease mechanisms.

• Sumatriptan Succinate: Anti-Inflammatory Actions Beyond Migr

  2026-05-19

  This article reviews a systematic analysis demonstrating that Sumatriptan Succinate, traditionally used for migraine, exerts significant anti-inflammatory effects through 5-HT1B/1D receptor agonism. The findings broaden the utility of this compound in research beyond headache models, with implications for neurovascular and inflammation-related studies.

• Diethylmaleate (B6151): Precision Redox Control for Lab Assa

  2026-05-19

  This article explores how Diethylmaleate (SKU B6151) provides robust, reproducible solutions for oxidative stress modeling, GST inhibition, and redox regulation in cell-based and toxicology assays. Drawing on recent literature and validated workflows, we detail practical scenarios where B6151’s quality, purity, and compatibility enable researchers to overcome common experimental pitfalls.

• Tivozanib (AV-951): Precision Anti-Angiogenesis for Translat

  2026-05-18

  This thought-leadership article explores how Tivozanib (AV-951), a next-generation VEGFR tyrosine kinase inhibitor, is reshaping translational oncology research. It bridges mechanistic insight with strategic workflow guidance, highlighting in vitro evaluation paradigms, clinical implications, and optimal protocol design for researchers seeking robust, reproducible anti-angiogenic data.

• Captopril Beyond Blood Pressure: Precision Tools for ACE and

  2026-05-18

  Explore how Captopril serves as a precision ACE inhibitor for hypertension and advanced bradykinin research. This article uncovers new mechanistic insights and practical guidance for translational applications.

• Berberine & Evodiamine Synergy: TRPV1/TAS2R38 Modulation in

  2026-05-17

  This study demonstrates that berberine and evodiamine act synergistically to alleviate gastroesophageal reflux disease (GERD) by targeting bitter taste receptor TAS2R38 and TRPV1, thereby modulating MAPK/NF-κB signaling and macrophage polarization. The findings elucidate a dual-receptor mechanism underlying esophageal epithelial protection and inflammation control, with direct implications for future GERD interventions.

• Hagenia abyssinica Extracts as Potent Molluscicides for Snai

  2026-05-16

  This study rigorously evaluated the molluscicidal activity of Hagenia abyssinica, Rosa abyssinica, and Cucumis ficifolius extracts against Biomphalaria and Bulinus snails, the intermediate hosts of schistosomiasis. Significant and selective activity was observed only for H. abyssinica, suggesting a promising, plant-derived alternative for schistosomiasis vector control with favorable safety margins.

• Mifepristone (RU486): Optimizing Cancer & Reproductive Workf

  2026-05-15

  Mifepristone (RU486) from APExBIO delivers robust, reproducible results in advanced cancer and reproductive biology assays by targeting progesterone receptor pathways. This guide translates bench evidence and literature-backed protocols into actionable workflows, troubleshooting, and optimization strategies that maximize experimental impact across cell-based and in vivo models.

• VE-822 ATR Inhibitor: Precision Tools for DDR Modulation

  2026-05-15

  VE-822 stands out as a next-generation ATR inhibitor, driving transformative advances in DNA damage response inhibition for cancer research. This article delivers actionable workflows, troubleshooting insights, and experimental strategies for maximizing the impact of VE-822 in pancreatic ductal adenocarcinoma and beyond.

• Valemetostat (DS-3201): Precision EZH2 Mutant Inhibition in

  2026-05-14

  Valemetostat (DS-3201) delivers highly selective dual EZH2/EZH1 inhibition, enabling reproducible and mutation-spanning epigenetic assays. This guide unpacks advanced workflows, troubleshooting, and comparative insights for optimizing lymphoma research and maximizing translational impact.

• IEM 1460: Advanced AMPA Receptor Blocker for Neuroprotection

  2026-05-14

  IEM 1460 empowers neuroscience labs to dissect glutamatergic signaling with high selectivity, supporting robust excitotoxicity and neuroprotection assays. This guide delivers workflow-driven protocol insights and troubleshooting strategies, translating cutting-edge reference findings into actionable experimental design.

462 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page